Divis Laboratories Ltd: Stock Analysis & Fundamentals

Updated this week

Divis Laboratories Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 62.8. ROE: 15.4%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

📊Debt increased 2150% YoY — leverage rising

🌐FII stake increased 2.1% this quarter

🏛️DII reducing — stake down 1.3%

Key Numbers

Current Price

₹5,998

Dividend Yield

0.50%

Market Cap

1.6L Cr

Valuation

N/A

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Gland Pharma Ltd

Average

+15.9%

Acutaas Chemicals Ltd

SMS Pharmaceuticals Ltd

Average • 12w streak

+37.7%

← Back to Pharma - API & CRAMS Dashboard

Frequently Asked Questions: Divis Laboratories Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Divis Laboratories Ltd's latest quarterly results?

Divis Laboratories Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: -1.0%
Revenue Growth YoY: +12.3%
Operating Margin: 34.0%

What is Divis Laboratories Ltd's current PE ratio?

Divis Laboratories Ltd's current PE ratio is 62.8x.

Current PE: 62.8x
Market Cap: 1.6 Lakh Cr
Dividend Yield: 0.50%

What is Divis Laboratories Ltd's price-to-book ratio?

Divis Laboratories Ltd's price-to-book ratio is 10.3x.

Price-to-Book (P/B): 10.3x
Book Value per Share: ₹581
Current Price: ₹5998

Is Divis Laboratories Ltd a fundamentally strong company?

Divis Laboratories Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 20.0%

Is Divis Laboratories Ltd debt free?

Divis Laboratories Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹4 Cr

What is Divis Laboratories Ltd's return on equity (ROE) and ROCE?

Divis Laboratories Ltd's return ratios over recent years

FY2023: ROCE 19.0%
FY2024: ROCE 16.0%
FY2025: ROCE 20.0%

Is Divis Laboratories Ltd's cash flow positive?

Divis Laboratories Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹2,000 Cr
Free Cash Flow (FCF): ₹849 Cr
CFO/PAT Ratio: 75% (adequate)

What is Divis Laboratories Ltd's dividend yield?

Divis Laboratories Ltd's current dividend yield is 0.50%.

Dividend Yield: 0.50%
Current Price: ₹5998

Who holds Divis Laboratories Ltd shares — promoters, FII, DII?

Divis Laboratories Ltd's shareholding pattern (Dec 2025)

Promoters: 51.9%
FII (Foreign): 20.1%
DII (Domestic): 19.2%
Public: 8.8%

Is promoter holding increasing or decreasing in Divis Laboratories Ltd?

Divis Laboratories Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 51.9% (Dec 2025)
Previous Quarter: 51.9% (Sep 2025)
Change: 0.00% (stable)

Is Divis Laboratories Ltd a new momentum entry or an established outperformer?

Divis Laboratories Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Divis Laboratories Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Divis Laboratories Ltd may be worth studying

Cash flow is positive — CFO ₹2,000 Cr

What is the investment thesis for Divis Laboratories Ltd?

Divis Laboratories Ltd investment thesis summary:

What is the future outlook for Divis Laboratories Ltd?

Divis Laboratories Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.